EP3661483A1 - 1,4 :3,6 dianhydrohexitols pour hydrater la peau - Google Patents

1,4 :3,6 dianhydrohexitols pour hydrater la peau

Info

Publication number
EP3661483A1
EP3661483A1 EP18758949.4A EP18758949A EP3661483A1 EP 3661483 A1 EP3661483 A1 EP 3661483A1 EP 18758949 A EP18758949 A EP 18758949A EP 3661483 A1 EP3661483 A1 EP 3661483A1
Authority
EP
European Patent Office
Prior art keywords
preparation
dianhydrohexitol
composition
skin
topical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP18758949.4A
Other languages
German (de)
English (en)
French (fr)
Inventor
Daniel Wils
Léon Mentink
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roquette Freres SA
Original Assignee
Roquette Freres SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roquette Freres SA filed Critical Roquette Freres SA
Publication of EP3661483A1 publication Critical patent/EP3661483A1/fr
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216Solid or semisolid forms
    • A61K8/022Powders; Compacted Powders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30Characterized by the absence of a particular group of ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Definitions

  • the invention relates to the non-therapeutic use of a composition based on 1, 4: 3,6 dianhydrohexitol, preferably based on isosorbide, to moisturize the skin.
  • a composition based on 1, 4: 3,6 dianhydrohexitol preferably based on isosorbide
  • glycerin Today the moisturizing agent of the skin most used in the field of cosmetics is glycerin. It is indeed contained in a large number of cosmetic products for topical use, such as creams, lotions, shower gels and shampoos, to give them moisturizing properties. However, glycerin has a number of sensory disadvantages when used in high amounts. Indeed, depending on the topical preparations retained, a glycerin content greater than 20%, or even greater than only 10% by weight relative to the weight of said preparation, causes the skin a greasy and sticky touch, considered unpleasant.
  • Patent Application EP 1 891 929 A1 describes the use of isosorbide as an anti-wrinkle agent in cosmetic preparations for the skin such as creams or lotions. According to this application, isosorbide reduces the thickening of the epidermis induced by photoaging, which results in a reduction of wrinkles. A moisturizing effect of isosorbide is neither described nor suggested.
  • one of the objectives of the present invention is to provide an alternative to glycerin which does not have the disadvantages of greasy and tacky touch.
  • the subject of the invention is the non-therapeutic use of a composition comprising at least one 1,4-3,6-dianhydrohexitol, in particular isosorbide, for moisturizing the skin as well as a composition for topical use comprising a composition comprising at least 1, 4: 3,6 dianhydrohexitol, this at least one 1,4: 3,6 dianhydrohexitol being in particular isosorbide, as moisturizing agent.
  • a composition comprising at least one 1,4-3,6-dianhydrohexitol, in particular isosorbide
  • the 1: 4, 3: 6 dianhydrohexitols prove to be moisturizing agents of the skin with a good moisturizing power, both instantaneously and lasting over time.
  • a topical preparation formulated with a composition comprising at least one 1,4: 3,6 dianhydrohexitol leaves a dry and powdery feel on the skin.
  • a composition comprising at least 1, 4: 3,6 dianhydrohexitol does not give rise to a greasy and sticky touch.
  • it provides a feeling of freshness greater than glycerin.
  • a topical preparation formulated with a composition comprising at least 1, 4: 3,6 dianhydrohexitol spreads more easily on the skin and penetrates better into the skin than a control preparation formulated with glycerine.
  • the moisturizing power is similar to the ability of a topical preparation to hydrate the superficial layer of the epidermis: the water contained in said preparation will be conveyed in this layer. From a sensory point of view, it results in a sensation of freshness.
  • This hydrating power can for example be measured by corneometry, a scientifically recognized method for measuring the hydration of the superficial layers of the skin, the implementation of which is explained in more detail in the examples section.
  • the moisturizing power should not be confused with other properties that are measured on the surface of the skin and not in the layers of the epidermis. This is for example the case of touch. Some characteristics of the touch do not depend on the moisturizing power: thus, a preparation for topical use can cause a greasy and sticky touch if it is for example glycerin-based, or conversely dry and powdery as in the case of the invention.
  • the touch can be influenced by the hydrating power: a better hydration of the upper layer of the epidermis makes the skin softer and more elastic. But in all cases, touch refers to a property that is measured on the surface of the skin, not in the layers of the epidermis.
  • 1,3,4,6-dianhydrohexitols also known simply as dianhydrohexitols or isohexides, are products of internal double dehydration of C6 polyols (hexitols) such as sorbitol, mannitol and iditol.
  • 1,4: 3,6 dianhydrohexitol includes isosorbide (1,4: 3,6 dianhydrosorbitol), isomannide (1,4: 3,6 dianhydromannitol), isoidide ( 1, 4: 3.6 dianhydroiditol).
  • the composition used in accordance with the invention may contain only 1, 4: 3,6 dianhydrohexitol, preferably isosorbide, or any mixture of the aforementioned 1,4, 3,6 dianhydrohexitols.
  • composition comprising at least one 1,4-4,6-dianhydrohexitol used according to the invention may be employed in solid form, preferably crystallized, especially in the form of powder or flakes, or in liquid form.
  • the composition in solid form, is not necessarily completely anhydrous and may therefore contain water in a small amount, especially up to about 5% by weight.
  • it is generally a paste or an aqueous solution of at least 1, 4: 3,6 dianhydrohexitol having a dry matter may be between 1 and 95% by weight.
  • 1, 4: 3,6 dianhydrohexitol it will be preferred that is to say having a dry matter greater than 30% by weight, preferably greater than 50% by weight and more preferably greater than 70% by weight.
  • a composition of 1,4: 3,6 dianhydrohexitol having a solids content of between 75% and 85% by weight.
  • the 1,4, 3,6 dianhydrohexitols being natural products resulting from the transformation of the starch, they always contain impurities such as for example caramelized sugars and products resulting from thermal reactions or Maillard. Therefore, they are generally used in the form of a composition whose dry weight content consists essentially of a single 1, 4: 3,6 dianhydrohexitol.
  • dry weight content consisting essentially of at least one 1,4-4,6-dianhydrohexitol means a content of 1,4-4,6-dianhydrohexitol of at least 75% by weight. dry / dry and preferably at least 90% dry weight / sec.
  • the presence of coloring or odorous impurities such as caramelized sugars and products resulting from thermal reactions or Maillard that may contain some of these compositions of 1, 4: 3,6 dianhydrohexitol unpurified will be limited to a content of dry weight less than 2%, better less than 1% and more preferably less than 0.5% relative to the total dry matter in 1, 4: 3,6 dianhydrohexitol of the composition.
  • the presence of coloring or odorous impurities is less than 0.2% relative to this dry matter and preferably less than 0.1% relative to this dry matter. More preferably still, the composition is colorless and is totally odor neutral.
  • composition used according to the invention will be prepared from or comprise a composition whose dry weight content consists essentially of a single 1, 4: 3,6 dianhydrohexitol, this dry weight content being at less than 98%, preferably at least 99% and more preferably at least 99.5%.
  • the composition used according to the invention may comprise several 1, 4: 3,6 dianhydrohexitols or a single 1,4-3,6 dianhydrohexitol, preferably isosorbide.
  • This composition may be used alone or as a mixture with other products that may be of interest for the formulation of the preparation for topical use, such as in particular other moisturizing agents such as betaine, sorbitol, xylitol, glycerin or acetamidoethoxyethanol or other active products or sensory effects vis-à-vis the skin, such as starch.
  • a composition in which the at least one 1,4-3,6 dianhydrohexitol is isosorbide is preferably employed.
  • this can be used in solid or liquid form, preferably having an isosorbide content of at least 98.5% by dry weight, preferably at least 99% by dry weight and more preferably still at least 99.5% by dry weight relative to the total dry matter.
  • isosorbide is used in liquid form.
  • the range of isosorbide marketed by the applicant company under the trade name POLYSORB® is particularly suitable for the purposes of the present invention.
  • the composition comprising at least one 1,4: 3,6 dianhydrohexitol, in particular the composition comprising isosorbide is incorporated in a preparation for topical use.
  • topical use is intended to mean any composition intended to be brought into contact with the skin, whether human or animal. It can thus be a cosmetic composition, a pharmaceutical composition or a veterinary composition.
  • preparations for topical use include lotions, creams, serums, gels, ointments, balms, liquid soaps or shower gels, shampoos, suds, foundations, antiperspirants and deodorants.
  • compositions may comprise, in addition to the composition comprising at least one 1,4-4,6-dianhydrohexitol, other ingredients usually used in topical preparations, such as, for example, cosmetic, pharmaceutical and / or veterinary active ingredients, and adjuvants such as as preservatives, solubilizers or perfumes. It may also comprise other moisturizing agents such as betaine, sorbitol, xylitol, glycerin or acetamidoethoxyethanol or other active or sensory effect products with regard to the skin, such as starch.
  • moisturizing agents such as betaine, sorbitol, xylitol, glycerin or acetamidoethoxyethanol or other active or sensory effect products with regard to the skin, such as starch.
  • the composition comprising at least one 1,4: 3,6 dianhydrohexitol can be used as a total or partial replacement of the glycerin usually used as a moisturizing agent in topical preparations. Preferably, it completely replaces glycerin.
  • the topical preparation is glycerin free.
  • the preparation for topical use may contain glycerol at a low content, especially less than or equal to 10%, preferably less than or equal to 5% and more preferably still less than or equal to 1% by weight relative to the total weight. of the preparation.
  • the total content of 1,4: 3,6 dianhydrohexitol of the preparation for topical use may be between 0.1% and 50%, preferably between 1% and 40%, more preferably between 5% and 30% and better. still between 10% and 25% by dry weight relative to the total weight of the preparation. It is understood that the use of the term "1, 4: 3,6 dianhydrohexitol" in the singular in the context of the content in the topical formulation means that it may be the content of a single 1, 4: 3,6 dianhydrohexitol or in several 1, 4: 3,6 dianhydrohexitols.
  • compositions comprising at least 1, 4: 3,6 dianhydrohexitol as hydrating agent have many advantages as explained above.
  • the use of at least 1, 4: 3,6 dianhydrohexitol as a moisturizing agent has the advantage of not giving a greasy and / or sticky touch but dry and powdery even when used at high levels, especially at total contents of 1, 4: 3,6 dianhydrohexitol greater than or equal to 10% by dry weight relative to the total weight of the composition.
  • the 1,4-4,6-dianhydrohexitol content of the preparation for topical use is advantageously greater than or equal to 10%, preferably greater than or equal to 15%, more preferably greater than or equal to 20% by dry weight relative to to the total weight of the preparation.
  • this content will not exceed 40%, preferably 30% and even more preferably 25% by dry weight relative to the total weight of the preparation.
  • the invention also relates to a topical preparation comprising a moisturizing agent, said moisturizing agent being a composition comprising at least one 1,4-4,6-dianhydrohexitol, as described above. As indicated above, this composition may in particular be free of glycerine.
  • the invention also relates to a skin hydration method comprising the application to the skin surface of a preparation for topical use as described above.
  • composition of the lotion was as follows (% by weight / total weight):
  • composition of the gel was as follows (% w / w): 6% by weight of isososorbide, sorbitol, xylitol, betaine or glycerin and 1% by weight of gelling carbomer in water.
  • the placebo consists of only 1% by weight of gelling carbomer in water.
  • the moisturizing efficacy of each of the preparations for topical use was evaluated by corneometry. Corneometry is a scientifically recognized method for measuring the hydration of the superficial layers of the skin. It is based on the determination of the capacitance of the superficial stratum corneum. The study was conducted with ten healthy volunteers, aged 18 to 65 years.
  • the moisturizing efficacy of each of the five formulas was evaluated 1 hour, 2 hours and 4 hours after its application to the laboratory on the inside of the forearm.
  • the evaluation was performed by comparing the hydration level of the area where the product was applied after 1 hour (T1 h), 2 hours (T2h) and 4 hours (T4h) with the level of hydration measured before application of the product (TO).
  • the Corneometer probe (surface 49 mm 2 ) is positioned perpendicular to the test area which has been previously delineated with a pencil. The capacitance measurement lasts 1 second. Each measurement is executed twice and the average of the two measurements is noted. The instrument gives the values in arbitrary units ranging from 0 to 130, with a margin of error of ⁇ 3%. Each volunteer sat for about 1 minutes in an air-conditioned room before each measurement with the Corneometer® to avoid abnormal results due to excessive sweating or stress.
  • Table 2 below reports the average hydration values expressed in arbitrary units (AU). The variations in hydration between TO and T1 h, T2h and T4h respectively are given in Table 3. Table 2
  • compositions of the two body milks evaluated correspond to those given in Example 1.
  • the two body milks are proposed in comparison and randomized for each panelist. Two pairs of products are evaluated per session
  • the panelist For each product, the panelist must evaluate the following descriptors on the surface of the epidermis: fresh, spreading, fat, sticky, soft, penetration. Each panelist scores the descriptors on a scale between 0 and 10. Assessment Protocol
  • the forearms are washed beforehand. Then, two application areas with a surface of 5cm 2 (1 x 5) are plotted on the forearm of each panelist for product evaluation. 0.2 g of each product is applied to the defined area for evaluation.
  • isosorbide-containing body milk as a moisturizing agent is significantly less tacky and fat than glycerin-based body milk. In addition, it spreads better, provides a greater sensation of freshness, is softer and more penetrating. In conclusion, the use of isosorbide as a total replacement for glycerin induces sensory benefits sought by the consumer that glycerine is not able to provide.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP18758949.4A 2017-08-02 2018-08-01 1,4 :3,6 dianhydrohexitols pour hydrater la peau Pending EP3661483A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1757421A FR3069775B1 (fr) 2017-08-02 2017-08-02 1,4 :3,6 dianhydrohexitols pour hydrater la peau
PCT/FR2018/051981 WO2019025730A1 (fr) 2017-08-02 2018-08-01 1,4 :3,6 dianhydrohexitols pour hydrater la peau

Publications (1)

Publication Number Publication Date
EP3661483A1 true EP3661483A1 (fr) 2020-06-10

Family

ID=60888472

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18758949.4A Pending EP3661483A1 (fr) 2017-08-02 2018-08-01 1,4 :3,6 dianhydrohexitols pour hydrater la peau

Country Status (9)

Country Link
US (1) US11464726B2 (ja)
EP (1) EP3661483A1 (ja)
JP (1) JP7324742B2 (ja)
KR (1) KR20200035032A (ja)
CN (1) CN110944621A (ja)
BR (1) BR112020001992B1 (ja)
CA (1) CA3071546A1 (ja)
FR (1) FR3069775B1 (ja)
WO (1) WO2019025730A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3094215B1 (fr) * 2019-03-28 2021-03-26 Roquette Freres Utilisation de dianhydrohexitol pour éliminer les effets cosmétique de l’acné
FR3094217A1 (fr) * 2019-03-28 2020-10-02 Roquette Freres Utilisation de dianhydrohexitol pour la conservation des préparations cosmétiques
JP2022526951A (ja) * 2019-03-28 2022-05-27 ロケット フレール ざ瘡、頭垢及び悪臭の美容上の影響を排除するためのジアンヒドロヘキシトールの使用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1436402A (en) * 2000-11-06 2002-05-15 Samyang Corp Transdermal drug delivery system with improved water absorbability and adhesion properties
TWI312687B (en) 2005-04-21 2009-08-01 Kao Corporatio Skin lotion and wrinkle improving agent
KR101499257B1 (ko) * 2005-10-31 2015-03-05 교와 가부시키가이샤 이소소르비드 제제
JP4667336B2 (ja) 2006-09-28 2011-04-13 花王株式会社 皮膚外用剤
ATE500817T1 (de) * 2008-12-23 2011-03-15 Intendis Gmbh Schäumbare zusammensetzung, die im wesentlichen frei von pharmazeutisch aktiven inhaltsstoffen ist, zur behandlung der menschlichen haut
US8496917B2 (en) * 2009-11-13 2013-07-30 Sytheon Ltd Compositions and methods for improving skin appearance
US20130183257A1 (en) * 2009-11-13 2013-07-18 Sytheon Ltd. Compositions and methods for improving skin appearance
CN103083282B (zh) * 2011-11-03 2015-11-18 杭州济迩斯生物科技有限公司 一种水凝胶疤痕贴及其制备工艺
CN102757445B (zh) * 2012-07-27 2014-06-25 山东福田药业有限公司 一种异山梨醇的制备工艺
FR3005315B1 (fr) * 2013-05-02 2015-06-05 Roquette Freres Procede de stabilisation d'une composition contenant au moins un produit de deshydratation interne d'un sucre hydrogene, composition obtenue et ses utilisations
EP2839828A1 (en) * 2013-08-23 2015-02-25 Nitto Denko Corporation Compunds and formulations for the treatment of wounds
US9605108B2 (en) * 2014-04-24 2017-03-28 New Jersey Institute Of Technology Isosorbide-derived epoxy resins and methods of making same

Also Published As

Publication number Publication date
FR3069775B1 (fr) 2020-02-14
CN110944621A (zh) 2020-03-31
FR3069775A1 (fr) 2019-02-08
US11464726B2 (en) 2022-10-11
JP2020529417A (ja) 2020-10-08
US20200230042A1 (en) 2020-07-23
BR112020001992B1 (pt) 2024-02-15
CA3071546A1 (fr) 2019-02-07
BR112020001992A2 (pt) 2020-08-18
WO2019025730A1 (fr) 2019-02-07
KR20200035032A (ko) 2020-04-01
JP7324742B2 (ja) 2023-08-10

Similar Documents

Publication Publication Date Title
KR101811849B1 (ko) 보습력 및 지속력이 우수한 화장료 조성물 및 이의 제조방법
JP4767914B2 (ja) 皮膚をひきしめる効果のある化粧組成物
WO2019025730A1 (fr) 1,4 :3,6 dianhydrohexitols pour hydrater la peau
CN110339146B (zh) 一种水包油包水粉底液及其制备方法
KR20060089898A (ko) Egcg와 장미 추출물을 함유하는 피부 외용제 조성물
WO2018020165A1 (fr) Produit cosmetique pour les levres sous la forme d'une emulsion eau-dans-huile et procede de maquillage
KR101189991B1 (ko) 백련초 추출물, 자작나무 수액, 엑스트라 버진 올리브 오일및 폴리올을 함유하는 피부 보습용 화장료 조성물
KR100879134B1 (ko) 수용성 성분 함유 오일형 화장료 조성물
KR101803271B1 (ko) 피부 보습용 또는 탄력 개선용 화장료 조성물
US20180353413A9 (en) Skin compositions containing hydrocortisone
EA027206B1 (ru) Композиция для ухода за кожей на основе растительного сырья, представляющая собой замену петролатуму
EP1644087A2 (fr) Procede de mise en evidence de l' activite drainante d'un traitement cosmetique et composition a activite drainante
JP3534945B2 (ja) 皮膚化粧料
WO2009010587A1 (fr) Utilisation d'au moins un extrait de parties aériennes de l'epilobe et/ou de l'onagre pour la préparation d'une composition destinée à restaurer la fonction barrière des tissus kératinisés ou des muqueuses.
FR3117371A1 (fr) Extrait de Mitracarpus scaber et son utilisation pour améliorer la fonction barrière et favoriser l’hydratation de la peau
KR101011356B1 (ko) 로즈마린산을 함유하는 스틱형 화장료 조성물
KR100836037B1 (ko) 꿀 제형을 갖는 화장료 조성물
KR102281403B1 (ko) 비자 세라마이드와 울금 및 동백유박 추출물을 포함하는 피부 주름 개선용 화장료 조성물
JPH08291018A (ja) 化粧品用保湿剤
CN108135792A (zh) 不含硅氧烷产品、基于维生素e的局部施用疏水性凝胶
KR20110032182A (ko) 오트 베타글루칸과 아베난쓰라마이드를 포함하는 색조 화장료용 복합분체 및 이를 포함하는 파우더 타입 색조 화장료 조성물
WO2021224575A1 (fr) Composition cosmetique comprenant au moins une algue rouge calcaire
FR3105731A1 (fr) Composition cosmétique et/ou dermatologique comprenant une association de glycyrrhétinate de stéaryle, de férulate d’éthyle et d’une huile végétale
WO2019158652A1 (fr) Composition cosmetique ou dermatologique et methode pour l'hydratation cutanee
KR20200061485A (ko) 쌀겨 추출 화장료 부스터의 제조 방법, 화장료 부스터 및 이를 이용한 화장료 조성물

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200122

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230316